Appia Bio Revenue and Competitors
Estimated Revenue & Valuation
- Appia Bio's estimated annual revenue is currently $10.8M per year.
- Appia Bio's estimated revenue per employee is $155,000
Employee Data
- Appia Bio has 70 Employees.
- Appia Bio grew their employee count by 35% last year.
Appia Bio's People
| Name | Title | Email/Phone |
|---|---|---|
1 | CEO | Reveal Email/Phone |
2 | CEO | Reveal Email/Phone |
3 | VP Regulatory Affairs | Reveal Email/Phone |
4 | Head Cell Therapy Quality | Reveal Email/Phone |
5 | Head Human Resources, Consultant | Reveal Email/Phone |
6 | SVP, Technical Operations | Reveal Email/Phone |
7 | VP, Head Regulatory Affairs | Reveal Email/Phone |
8 | VP, Quality | Reveal Email/Phone |
9 | Director, Engineering, Facilities, Operations | Reveal Email/Phone |
10 | Director, Product Analytical Sciences | Reveal Email/Phone |
Appia Bio Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $99.4M | 458 | 40% | N/A | N/A |
#2 | $20.6M | 133 | 22% | N/A | N/A |
#3 | $156.1M | 146 | -70% | $145M | N/A |
#4 | $3.5M | 45 | -25% | $150M | N/A |
#5 | $1.6M | 21 | 0% | $459.5M | N/A |
#6 | $67.3M | 310 | 16% | $180.7M | N/A |
#7 | $8.5M | 55 | -2% | N/A | N/A |
#8 | $256.3M | 1025 | 9% | $168.5M | N/A |
#9 | $2.8M | 18 | -33% | N/A | N/A |
#10 | $9.1M | 59 | -9% | N/A | N/A |
What Is Appia Bio?
N/A
Total Funding
70
Number of Employees
$10.8M
Revenue (est)
35%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Appia Bio News
2022-04-17 - Kite Receives US FDA Approval of New State-of-the-Art CAR T-Cell ...
... pipeline deals for the next generation of cell therapies, including previously announced deals with Appia Bio and Shoreline Biosciences.
2022-04-17 - Global Cancer Stem Cells Market Estimated to Surpass
Appia Bio is highly focused on discovering as well as developing off-the-shelf (OTS) allogeneic cell therapies across a wide array of cancer...
2022-04-06 - FDA Approves Kite Pharmas Cancer Drug Yescarta
Culver City-based Appia Bio, meanwhile, emerged from stealth last spring to create off-the-shelf cell therapies that can be delivered quicker and cheaper to...
Other Companies in
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $7.5M | 70 | 37% | N/A |
#2 | $17M | 70 | 17% | N/A |
#3 | $9.1M | 70 | -29% | N/A |
#4 | $12.9M | 70 | 19% | N/A |
#5 | $3.5M | 70 | 9% | N/A |